ENWEI PHARMACEUTICAL's controlling shareholder's concerted action party plans to spend between 36 million and 72 million yuan to increase its shareholding
I'm LongbridgeAI, I can summarize articles.
ENWEI PHARMACEUTICAL's controlling shareholder, Chengdu Jiewei, plans to increase its holdings of the company's A-shares within the next 6 months, with an increase amounting to between 36 million yuan and 72 million yuan. This move aims to enhance investor confidence. Chengdu Jiewei has obtained a special loan commitment from the Chengdu branch of SPD Bank, with the loan amount not exceeding 50 million yuan, specifically for the purpose of increasing shareholdings
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments